Ad is loading...
JAWGX
Price
$73.72
Change
+$0.12 (+0.16%)
Updated
Nov 22 closing price
RNPEX
Price
$64.39
Change
+$0.26 (+0.41%)
Updated
Nov 22 closing price
Ad is loading...

JAWGX vs RNPEX

Header iconJAWGX vs RNPEX Comparison
Open Charts JAWGX vs RNPEXBanner chart's image
Janus Henderson VIT Global Rsrch Instl
Price$73.72
Change+$0.12 (+0.16%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R4
Price$64.39
Change+$0.26 (+0.41%)
VolumeN/A
CapitalizationN/A
JAWGX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JAWGX vs. RNPEX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAWGX is a Buy and RNPEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 144B vs. JAWGX (930M). RNPEX pays higher dividends than JAWGX: RNPEX (0.83) vs JAWGX (0.74). JAWGX was incepted earlier than RNPEX: JAWGX (31 years) vs RNPEX (23 years). JAWGX is a more actively managed with annual turnover of: 25.00 vs. RNPEX (17.00). JAWGX has a lower initial minimum investment than RNPEX: JAWGX (0) vs RNPEX (250). JAWGX annual gain was more profitable for investors over the last year : 27.50 vs. RNPEX (18.38). JAWGX (41.48) and RNPEX (41.31) have equivalent 5 years return.
JAWGXRNPEXJAWGX / RNPEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years23 years-
Gain YTD21.21817.329122%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets930M144B1%
Annual Yield % from dividends0.740.8389%
Returns for 1 year27.5018.38150%
Returns for 3 years6.33-6.97-91%
Returns for 5 years41.4841.31100%
Returns for 10 years90.1568.16132%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG35.332.95
+9.11%
Bright Minds Biosciences
HWC59.972.07
+3.58%
Hancock Whitney Corp
ECPG49.141.10
+2.29%
Encore Capital Group
BR230.242.77
+1.22%
Broadridge Financial Solutions
CTXR0.13-0.03
-18.96%
Citius Pharmaceuticals